This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Recruiting now

Conditions studied: Atopic Dermatitis

In brief

The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. Additionally, patient-specific factors (such as age, skin color, AD flare triggers, previous treatment responses, comorbid conditions, and the extent and site of lesions) will be assessed to better characterize the impact on the treatment journey across a broad age range and diverse geographic regions. The study will be conducted across 10 countries in 4 different geographical regions, with a follow-up period of 5 years.

Key facts

Study ID

NCT07290803

Run by

Sanofi

People needed

1000

Starts

2025-11-17

Expected to finish

2034-01-30

Last updated by the study team

2026-08-06

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged more than or equal to (≥) 12 years at the time of consent.
• Confirmed diagnosis of AD, of any severity, according to the Investigator's assessment as aligned with International Classification of Diseases 10th revision (ICD-10) code of L20.
• Prescribed and scheduled to initiate any systemic treatment for AD (including but not limited to biologics, oral Janus kinase (JAK) inhibitors, cyclosporine, azathioprine, methotrexate, mycophenolate mofetil)
• Signed informed consent for registry participation by the patient or parent/legal representative and assent by the patient appropriate to the patient's age, including willingness to participate in long-term follow-up.

You may not qualify if…

• Concurrent participation in an interventional clinical trial that administers an investigational drug that modifies patient care.
• Insufficient understanding of the study by the patient and/or parent/guardian.
• The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Where it is running

• River Region Dermatology and Laser- Site Number : 8400041 — Montgomery, Alabama, United States (enrolling)
• San Tan Allergy & Asthma- Site Number : 8400031 — Gilbert, Arizona, United States (enrolling)
• Saguaro Dermatology- Site Number : 8400028 — Phoenix, Arizona, United States (enrolling)
• Kern Research, Inc.- Site Number : 8400047 — Bakersfield, California, United States (enrolling)
• Center for Dermatology Clinical Research- Site Number : 8400014 — Fremont, California, United States (enrolling)
• Dermatology Research Associates - Los Angeles- Site Number : 8400020 — Los Angeles, California, United States (enrolling)
• Northridge Clinical Trials, LLC- Site Number : 8400009 — Northridge, California, United States (enrolling)
• Sunwise Clinical Research, LLC.- Site Number : 8400010 — Oakland, California, United States (enrolling)
• Empire Clinical Research, LLC- Site Number : 8400007 — Pomona, California, United States (enrolling)
• University Clinical Trials- Site Number : 8400019 — San Diego, California, United States (enrolling)
• Western States Clinical Research, Inc.- Site Number : 8400051 — Wheat Ridge, Colorado, United States (enrolling)
• St. Jude Clinical Research- Site Number : 8400049 — Doral, Florida, United States (enrolling)
• Ziaderm Research, LLC- Site Number : 8400021 — North Miami Beach, Florida, United States (enrolling)
• Skin Care Physicians of Georgia - Macon- Site Number : 8400034 — Macon, Georgia, United States (enrolling)
• Sneeze, Wheeze, & Itch Associates, LLC- Site Number : 8400029 — Normal, Illinois, United States (enrolling)
• Rosalind Franklin University of Medicine and Science- Site Number: 8400056 — North Chicago, Illinois, United States (enrolling)
• David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017 — Ann Arbor, Michigan, United States (enrolling)
• Oakland Hills Dermatology- Site Number : 8400042 — Auburn Hills, Michigan, United States (enrolling)
• Great Lakes Research Group - Bay City- Site Number : 8400052 — Bay City, Michigan, United States (enrolling)
• The Derm Institute of West Michigan- Site Number : 8400025 — Caledonia, Michigan, United States (enrolling)
• Wayne State University - Detroit Medical Center- Site Number : 8400035 — Detroit, Michigan, United States (enrolling)
• Michigan Dermatology Institute - Waterford- Site Number : 8400013 — Waterford, Michigan, United States (enrolling)
• Red River Research Partners, Llc- Site Number : 8400054 — Bolivar, Missouri, United States (enrolling)
• Cleaver Dermatology- Site Number : 8400033 — Kirksville, Missouri, United States (enrolling)
• Cahaba Dermatology & Skin Health Center- Site Number : 8400006 — Birmingham, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.